JPMorgan raised the firm’s price target on Imax (IMAX) to $27 from $25 and keeps a Neutral rating on the shares. The firm updated estimates ...
Overall quarterly revenue was $92.7 million, up 8 percent from a year-earlier $86 million, as ‘Gladiator II,’ ‘Venom: The ...